These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24282351)

  • 1. Branched-chain amino acids in liver diseases.
    Tajiri K; Shimizu Y
    World J Gastroenterol; 2013 Nov; 19(43):7620-9. PubMed ID: 24282351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
    Holecek M
    Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched-chain amino acid supplementation in patients with liver diseases.
    Marchesini G; Marzocchi R; Noia M; Bianchi G
    J Nutr; 2005 Jun; 135(6 Suppl):1596S-601S. PubMed ID: 15930476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on branched-chain amino acid supplementation in liver diseases.
    Bianchi G; Marzocchi R; Agostini F; Marchesini G
    Curr Opin Gastroenterol; 2005 Mar; 21(2):197-200. PubMed ID: 15711213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride.
    Ichikawa K; Okabayashi T; Shima Y; Iiyama T; Takezaki Y; Munekage M; Namikawa T; Sugimoto T; Kobayashi M; Mimura T; Hanazaki K
    Mol Biol Rep; 2012 Dec; 39(12):10803-10. PubMed ID: 23053977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
    Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M
    Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched chain amino acid therapy in liver disease.
    Maddrey WC
    J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy.
    Zhang Y; Zhan L; Zhang L; Shi Q; Li L
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New support for branched-chain amino acid supplementation in advanced hepatic failure.
    Mascarenhas R; Mobarhan S
    Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acids in liver diseases.
    Tajiri K; Shimizu Y
    Transl Gastroenterol Hepatol; 2018; 3():47. PubMed ID: 30148232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease.
    Colosimo S; Bertoli S; Saffioti F
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease.
    Kuwahata M; Kubota H; Kanouchi H; Ito S; Ogawa A; Kobayashi Y; Kido Y
    Nutr Res; 2012 Jul; 32(7):522-9. PubMed ID: 22901560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
    Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.
    Tada T; Kumada T; Toyoda H; Yasuda S; Koyabu T; Nakashima M
    Nutr Cancer; 2019; 71(7):1132-1141. PubMed ID: 30955354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness.
    Azuma Y; Maekawa M; Kuwabara Y; Nakajima T; Taniguchi K; Kanno T
    Clin Chem; 1989 Jul; 35(7):1399-403. PubMed ID: 2758584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies.
    Morgan MY
    J Hepatol; 1990 Sep; 11(2):133-41. PubMed ID: 2254623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.